Evidence map›Paper›PMID 38727848›Full record

ReviewMolecular biology reports2024

Beneficial effects of metformin treatment on memory impairment.

Mohammad Pourfridoni, Mahdiyeh Hedayati-Moghadam, Shirin Fathi, Shiva Fathi, Fatemeh Sadat Mirrashidi, Hedyeh Askarpour, Hadi Shafieemojaz, Yousef Baghcheghi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad PourfridoniStudent Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.
Mahdiyeh Hedayati-MoghadamStudent Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.
Shirin FathiDepartment of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiva FathiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Fatemeh Sadat MirrashidiDepartrment of Pediatrics, Jiroft University of Medical Sciences, Jiroft, Iran.
Hedyeh AskarpourStudent Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.
Hadi ShafieemojazStudent Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran.
Yousef BaghcheghiStudent Research Committee, Jiroft University of Medical Sciences, Jiroft, Iran. Y.baghcheghi@jmu.ac.ir.ORCID http://orcid.org/0000-0002-3292-2558

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Memory issues are a prevalent symptom in different neurodegenerative diseases and can also manifest in certain psychiatric conditions. Despite limited medications approved for treating memory problems, research suggests a lack of sufficient options in the market. Studies indicate that a significant percentage of elderly individuals experience various forms of memory disorders. Metformin, commonly prescribed for type 2 diabetes, has shown neuroprotective properties through diverse mechanisms. This study explores the potential of metformin in addressing memory impairments. The current research gathered its data by conducting an extensive search across electronic databases including PubMed, Web of Science, Scopus, and Google Scholar. Previous research suggests that metformin enhances brain cell survival and memory function in both animal and clinical models by reducing oxidative stress, inflammation, and cell death while increasing beneficial neurotrophic factors. The findings of the research revealed that metformin is an effective medication for enhancing various types of memory problems in numerous studies. Given the rising incidence of memory disorders, it is plausible to utilize metformin, which is an affordable and accessible drug. It is often recommended as a treatment to boost memory.

Indexed as

Memory DisordersMetforminAnimalsBrainHumansHypoglycemic AgentsMemoryNeuroprotective AgentsOxidative StressHypoglycemic AgentsMetforminNeuroprotective AgentsMemory disordersMemory impairmentMetforminNeuroprotective

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.